BR0300301A - Método para afetar comportamentos durante o sono e relacionados ao sono - Google Patents

Método para afetar comportamentos durante o sono e relacionados ao sono

Info

Publication number
BR0300301A
BR0300301A BR0300301-9A BR0300301A BR0300301A BR 0300301 A BR0300301 A BR 0300301A BR 0300301 A BR0300301 A BR 0300301A BR 0300301 A BR0300301 A BR 0300301A
Authority
BR
Brazil
Prior art keywords
sleep
adrenocortical hormone
level
affecting
reducing
Prior art date
Application number
BR0300301-9A
Other languages
English (en)
Portuguese (pt)
Inventor
Laura Mcculloch
Benjamin Carls Wiegand
Original Assignee
Johnson & Johnson Consumer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer filed Critical Johnson & Johnson Consumer
Publication of BR0300301A publication Critical patent/BR0300301A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4806—Sleep evaluation
    • A61B5/4815—Sleep quality
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2228—Corticotropin releasing factor [CRF] (Urotensin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
    • A61M2021/0016—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the smell sense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
    • A61M2021/0022—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the tactile sense, e.g. vibrations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
    • A61M2021/0027—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the hearing sense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
    • A61M2021/0044—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the sight sense

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acoustics & Sound (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Surgery (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
BR0300301-9A 2002-02-08 2003-02-07 Método para afetar comportamentos durante o sono e relacionados ao sono BR0300301A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0203045.0A GB0203045D0 (en) 2002-02-08 2002-02-08 Method of afefecting sleep and sleep-related behaviours

Publications (1)

Publication Number Publication Date
BR0300301A true BR0300301A (pt) 2004-08-03

Family

ID=9930734

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0300301-9A BR0300301A (pt) 2002-02-08 2003-02-07 Método para afetar comportamentos durante o sono e relacionados ao sono

Country Status (10)

Country Link
US (2) US20030225095A1 (US20070275102A9-20071129-P00001.png)
EP (1) EP1342489A1 (US20070275102A9-20071129-P00001.png)
JP (1) JP2003260138A (US20070275102A9-20071129-P00001.png)
KR (1) KR20030067595A (US20070275102A9-20071129-P00001.png)
CN (1) CN1457902A (US20070275102A9-20071129-P00001.png)
BR (1) BR0300301A (US20070275102A9-20071129-P00001.png)
CA (1) CA2417305A1 (US20070275102A9-20071129-P00001.png)
GB (1) GB0203045D0 (US20070275102A9-20071129-P00001.png)
MX (1) MXPA03001202A (US20070275102A9-20071129-P00001.png)
TW (1) TW200514558A (US20070275102A9-20071129-P00001.png)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2384563A (en) * 2002-01-29 2003-07-30 Johnson & Johnson Consumer Method of measuring the stress or relaxation level of a mammal
KR100691860B1 (ko) * 2003-12-08 2007-03-12 주식회사 대양이앤씨 산란계의 산란율을 증가시키는 음원 시스템
US20060019224A1 (en) * 2004-07-23 2006-01-26 Pics, Inc. Insomnia assessment and treatment device and method
GB2418143B (en) * 2004-09-21 2010-03-17 Can Do Corp Ltd Apparatus for behaviour modification
US9131079B2 (en) 2005-02-07 2015-09-08 Robert A. Oklejas System and method for providing a television network customized for an end user
US10219035B2 (en) 2005-02-07 2019-02-26 Robert A. Oklejas System and method for providing a television network customized for an end user
US8151315B2 (en) * 2005-02-07 2012-04-03 Oklejas Robert A Hybrid audio/video entertainment system
TWI370820B (en) 2005-04-27 2012-08-21 Takeda Pharmaceutical Fused heterocyclic compounds
US20070150310A1 (en) * 2005-12-27 2007-06-28 Benjamin Wiegand A method of motivating an individual to improve lifestyle factors
US20070150204A1 (en) * 2005-12-27 2007-06-28 Benjamin Wiegand Methods for recommending a program to improve or maintain pro-inflammatory immune health
US20070150205A1 (en) * 2005-12-27 2007-06-28 Benjamin Wiegand Methods for assessing the pro-inflammatory immune health of an individual
US20070150203A1 (en) * 2005-12-27 2007-06-28 Benjamin Wiegand A kit for assessing the pro-inflammatory immune health of an individual
US20070150202A1 (en) * 2005-12-27 2007-06-28 Benjamin Wiegand A method for assessing the efficacy of a program to improve or maitain the pro-inflammatory immune health
US20070270393A1 (en) * 2006-02-17 2007-11-22 Theresa Buckley Methods and compositions for modulation of sleep cycle
US20100048984A1 (en) * 2008-08-21 2010-02-25 Anderson Troy G Integrated Sleep Aid Control Center and Method Therefor
WO2014115053A1 (en) * 2013-01-23 2014-07-31 Koninklijke Philips N.V. Means for assisting human information processing
JP6488485B2 (ja) * 2014-09-19 2019-03-27 ソニー株式会社 状態制御装置、状態制御方法、および状態制御システム
WO2018045483A1 (zh) * 2016-09-06 2018-03-15 深圳市赛亿科技开发有限公司 睡眠辅助系统
US20200360654A1 (en) * 2019-05-17 2020-11-19 Karen Hanlon Grove System and method for a therapeutic box
CN116150591B (zh) * 2023-04-04 2023-06-20 安徽星辰智跃科技有限责任公司 一种睡眠感官应激水平检测量化的方法、系统和装置

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1019866B (it) * 1974-08-09 1977-11-30 Biomedix Ag Apparecchiatura per la determinazio ne della concentrazione di emoglobi na totale ossigenata e risotta car bossiemoglobina del la capacita dell emoglobina per lo ossigeno della saturazione per centuale in ossigeno e in ossido di carbonio nel sangue o in solu zioni di emoglobina
US4950649A (en) * 1980-09-12 1990-08-21 University Of Illinois Didemnins and nordidemnins
EP0053754B1 (de) * 1980-12-06 1986-04-23 Reichert, Dietrich, Dr. med. Mittel zur Bekämpfung des Schnarchens und Verfahren zu dessen Anwendung
US4375421A (en) * 1981-10-19 1983-03-01 Lever Brothers Company Viscous compositions containing amido betaines and salts
LU84752A1 (fr) * 1983-04-15 1984-11-28 Oreal Composition lavante et moussante a base d'agents tensio-actifs et de polymeres anioniques
LU84753A1 (fr) * 1983-04-15 1984-11-28 Oreal Composition lavante et moussante a base d'agents tensio-actifs non ioniques et de polymeres anioniques
US4670463A (en) * 1984-11-14 1987-06-02 Yale University Method of causing the reduction of physiological and/or subjective reactivity to stress in humans being subjected to stress conditions
JPS61267526A (ja) * 1984-11-14 1986-11-27 インタ−ナシヨナル　フレイバ−ス　アンド　フレグランシス　インコ−ポレイテツド 人間のストレスに対する生理的及び、又は主観的反応性を減少させる医薬
US4671959A (en) * 1984-11-14 1987-06-09 Yale University Method of causing the reduction of physiological and/or subjective reactivity to stress in humans being subjected to stress conditions
EP0269107A3 (en) * 1986-11-28 1989-10-11 Kao Corporation Composition for hair treatment agent
US4877322A (en) * 1987-04-30 1989-10-31 Eyedentify, Inc. Method and apparatus for measuring blood oxygen levels in selected areas of the eye fundus
FR2632519B1 (fr) * 1988-06-14 1992-02-21 Oreal Composition parfumante, a phase aqueuse continue, ayant une forte concentration en parfum
US5564417A (en) * 1991-01-24 1996-10-15 Non-Invasive Technology, Inc. Pathlength corrected oximeter and the like
US5711899A (en) * 1988-12-23 1998-01-27 Henkel Kommanditgesellschaft Auf Aktien Free flowing pearlescent concentrate
DE3930725A1 (de) * 1989-09-14 1991-03-21 Benckiser Gmbh Joh A Extra-milde duschgel- und haarshampoo-formulierung mit niedriger tensidkonzentration
US5063062A (en) * 1989-09-27 1991-11-05 D. Greenspan Cleaning compositions with orange oil
AU630561B2 (en) * 1990-06-12 1992-10-29 Cathy Palou A therapeutic preparation containing myrrh for treating skin disorders
US5614553A (en) * 1990-07-06 1997-03-25 Albion Laboratories, Inc. Composition and method for alleviating stress in warm-blooded animals
US5304112A (en) * 1991-10-16 1994-04-19 Theresia A. Mrklas Stress reduction system and method
US5275761A (en) * 1992-04-15 1994-01-04 Helene Curtis, Inc. Conditioning shampoo composition and method of preparing and using the same
US5403263A (en) * 1992-05-21 1995-04-04 P.I.P. Surgical Audiotape Series, Inc. Method of reducing the recovery time and stress associated with surgery
US5284603A (en) * 1992-06-03 1994-02-08 Colgate Palmolive Co. Gelled detergent composition having improved skin sensitivity
US5497771A (en) * 1993-04-02 1996-03-12 Mipm Mammendorfer Institut Fuer Physik Und Medizin Gmbh Apparatus for measuring the oxygen saturation of fetuses during childbirth
US5403587A (en) * 1993-04-22 1995-04-04 Eastman Kodak Company Disinfectant and sanitizing compositions based on essential oils
US5578312A (en) * 1993-05-05 1996-11-26 Parrinello; Vincene M. Skin care system and method for improving moisture retention in skin
GB9321479D0 (en) * 1993-10-18 1993-12-08 Scotia Holdings Plc Stabilisation of polyunsaturates
US5597406A (en) * 1993-11-02 1997-01-28 Henkel Corporation Method of thickening aqueous formulations
US5501813A (en) * 1993-11-02 1996-03-26 Henkel Corporation Thickener for aqueous compositions
US5466446A (en) * 1994-02-16 1995-11-14 Stiefel Laboratories, Inc. Topical compositions containing bensoyl peroxide and clindamycin and method of use thereof
DE4416566A1 (de) * 1994-05-11 1995-11-16 Huels Chemische Werke Ag Wäßrige viskoelastische Tensidlösungen zur Haar- und Hautreinigung
MX9605996A (es) * 1994-05-31 1997-12-31 Procter & Gamble Composiciones limpiadoras.
US5540853A (en) * 1994-10-20 1996-07-30 The Procter & Gamble Company Personal treatment compositions and/or cosmetic compositions containing enduring perfume
US5849310A (en) * 1994-10-20 1998-12-15 The Procter & Gamble Company Personal treatment compositions and/or cosmetic compositions containing enduring perfume
US5716919A (en) * 1995-05-09 1998-02-10 The Andrew Jergens Company Mild cleansing formulation with a hydroxy-containing compound, a nonionic surfactant and an anionic surfactant
US5607980A (en) * 1995-07-24 1997-03-04 The Procter & Gamble Company Topical compositions having improved skin feel
US5771261A (en) * 1995-09-13 1998-06-23 Anbar; Michael Telethermometric psychological evaluation by monitoring of changes in skin perfusion induced by the autonomic nervous system
US5855884A (en) * 1995-11-27 1999-01-05 Kos Pharmaceuticals, Inc. Treatment of stress-induced migraine headache with a corticotropin releasing hormone blocker
JPH09227399A (ja) * 1996-02-27 1997-09-02 Pola Chem Ind Inc 副腎皮質ホルモン分泌抑制剤
JPH09227400A (ja) * 1996-02-28 1997-09-02 Pola Chem Ind Inc 副腎皮質ホルモン分泌抑制剤
US5904916A (en) * 1996-03-05 1999-05-18 Hirsch; Alan R. Use of odorants to alter learning capacity
US5792739A (en) * 1996-04-24 1998-08-11 Lever Brothers Company, Division Of Conopco, Inc. Liquid compositions comprising hydrophobically modified polyalkylene glycols as mildness actives
US5789953A (en) * 1996-05-29 1998-08-04 Integrated Device Technology, Inc. Clock signal generator providing non-integer frequency multiplication
US5804538A (en) * 1996-06-20 1998-09-08 The Procter & Gamble Company Perfume delivery systems in liquid personal cleansing compositions
US5753637A (en) * 1996-10-09 1998-05-19 Ideal Ideas, Inc. Method of treating acne conditions
US5922331A (en) * 1997-03-26 1999-07-13 Chanel, Inc. Skin cream composition
US5958462A (en) * 1997-05-23 1999-09-28 Mclean; Linsey Therapeutic bath salts and method of use
US5916576A (en) * 1997-05-30 1999-06-29 Amway Corporation Method of scavenging free radicals using orange extract
JPH1119076A (ja) * 1997-07-07 1999-01-26 Pola Chem Ind Inc 香りの抗ストレス効果の測定法
JPH1123579A (ja) * 1997-07-07 1999-01-29 Pola Chem Ind Inc マッサージの評価方法
EP1012151B1 (en) * 1997-09-02 2002-08-07 Bristol-Myers Squibb Pharma Company Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (crh) antagonists, useful for treating cns and stress-related disorders
US5980925A (en) * 1997-12-30 1999-11-09 Ethicon, Inc. High glycerin containing anti-microbial cleansers
JP2000053532A (ja) * 1998-08-04 2000-02-22 Shiseido Co Ltd 美容法
US6432989B1 (en) * 1999-08-27 2002-08-13 Pfizer Inc Use of CRF antagonists to treat circadian rhythm disorders
EP1218023B8 (en) * 1999-10-01 2006-05-03 Johnson & Johnson Consumer Companies, Inc. Method for calming human beings using personal care compositions
DE19952970A1 (de) * 1999-11-03 2001-05-31 Peter Neuhaus Der Entspannung,dem Relaxen oder der Meditation dienende Pyramide
US20020090664A1 (en) * 2000-12-20 2002-07-11 Benjamin Wiegand Methods for measuring stress in mammals
US20020146469A1 (en) * 2000-12-20 2002-10-10 Benjamin Wiegand Methods for reducing chronic stress in mammals
US20020151527A1 (en) * 2000-12-20 2002-10-17 Benjamin Wiegand Method for reducing acne or improving skin tone
US6428466B1 (en) * 2001-02-14 2002-08-06 Simulated Environment Concepts, Inc. Spa capsule
US20030005409A1 (en) * 2001-07-02 2003-01-02 Pradeep Tumati System and method for modifying software without halting its execution
GB2384563A (en) * 2002-01-29 2003-07-30 Johnson & Johnson Consumer Method of measuring the stress or relaxation level of a mammal
US20040175438A1 (en) * 2003-03-03 2004-09-09 Benjamin Wiegand Methods for alleviating symptoms associated with menopause using sensory regimen

Also Published As

Publication number Publication date
KR20030067595A (ko) 2003-08-14
CN1457902A (zh) 2003-11-26
GB0203045D0 (en) 2002-03-27
MXPA03001202A (es) 2004-09-06
CA2417305A1 (en) 2003-08-08
JP2003260138A (ja) 2003-09-16
EP1342489A1 (en) 2003-09-10
TW200514558A (en) 2005-05-01
US20070275102A9 (en) 2007-11-29
US20030225095A1 (en) 2003-12-04
US20070149492A1 (en) 2007-06-28

Similar Documents

Publication Publication Date Title
BR0300301A (pt) Método para afetar comportamentos durante o sono e relacionados ao sono
Yap et al. Sleep bruxism: Current knowledge and contemporary management
Murali et al. Bruxism: Conceptual discussion and review
Lavigne et al. Genesis of sleep bruxism: motor and autonomic-cardiac interactions
KR100315389B1 (ko) 중추유래의수면성무호흡증및호흡곤란증에효과를갖는약제를제조하기위한모다피닐의사용
CU23468B7 (es) Forma de dosificación de pramipexol en una dosis única diaria
RU2008119454A (ru) Лекарственное средство для защиты моторного нейрона у пациентов с боковым амиотрофическим склерозом
BR0315846A (pt) Tratamento farmacológico para apnéia do sono
Iwata et al. Operant control of seizure-like behavior in an institutionalized retarded adult
JP2004532215A (ja) 睡眠時の自律的安定性に関するカンナビノイドの機能的役割
JP5030553B2 (ja) ドライマウスおよび／または唾液分泌障害を処置するための医薬
BR0308229A (pt) Medicamentos contendo ingredientes ativos que diminuem o nìvel de colesterol com liberação do ingrediente ativo de tempo tardio
Yoshida Oral device therapy for the upper airway resistance syndrome patient
WO2008061612A1 (en) Use of arginase inhibitors in the treatment of asthma and allergic rhinitis
TR199701497T1 (xx) Beyin �demini �nleyen terkip.
Snyder et al. NIH studies of EEG sleep in affective illness
US6818665B2 (en) Treatment of obstructive sleep apnea
Stone et al. Glucose attenuation of atropine-induced deficits in paradoxical sleep and memory
Romero et al. Prevention of habitual cheek biting: a case report
Kim et al. Transdermal scopolamine alters phasic REM activity in normal young adults
Wexler et al. Effects of a muramyl dipeptide on the temperature and sleep-wake cycles of the squirrel monkey
BR0313503A (pt) Método de tratamento de sìndrome das pernas inquietas, uso do antagonista de receptor da adenoina a2a, agente terapêutico para sìndrome das pernas inquietas, e, método de tratamento da mioclonia noturna
BR0308396A (pt) Processo de tratamento de diabetes mellitus incluindo condições associadas com diabetes mellitus e complicações de diabetes mellitus
SE9303612D0 (sv) New use
Bradshaw What are the nonsurgical treatment options for obstructive sleep apnea syndrome?

Legal Events

Date Code Title Description
B03H Publication of an application: rectification [chapter 3.8 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT.CL: A61K 31/00

Ipc: A61K 38/22 (2006.01), A61K 45/00 (2006.01), A61M 2

B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 11A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2246 DE 21/01/2014.